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Proportion of asylum seekers carrying
multi-drug resistant microorganisms is
persistently increased after arrival in the
Netherlands
Sofanne J. Ravensbergen1,2*, Christina Louka1,2, Alewijn Ott3, John W. Rossen2,4,5, Darren Cornish6,
Spyros Pournaras7, Erik Bathoorn4 and Ymkje Stienstra1,2
Abstract
Background: Several studies have shown a high prevalence of multi-drug resistant organisms (MDRO) amongst
asylum seekers when compared to the general population. The aim of this study is to assess the duration of MDRO
carriage in this population.
Methods: Data were retrospectively collected between January 1st 2014 through December 31st 2016. Study material
included screening samples for MDRO carriage and clinical samples from asylum seekers in need of medical care. The
study focused on methicillin-resistant Staphylococcus aureus (MRSA) and multi-drug resistant Enterobacteriaceae
(MDRE). The rates of MRSA and MDRE detected were calculated every four weeks after arrival in the Netherlands.
Results: Samples from 2091 asylum seekers were included. 1270 (60.7%) were female, median age was 26 years (IQR
20–34) and median number of days in the Netherlands until first sample was 67 (IQR 4–235). In the patients’ first
obtained samples, the rate of MRSA varied between 4.5 and 13.0% per time interval after arrival. The rate of MDRE
fluctuated between 7.4% and 25.0%. No particular decline in positivity rates in first obtained samples was observed
after arrival in the Netherlands. In the group of asylum seekers who arrived more than one year ago, MRSA was isolated
in a percentage of 5.1% (n = 273, median months after arrival 34.1 (IQR 16.5–63.1)) and MDRE in 9.4% (n = 276, median
months after arrival 35.4 (IQR 17–65)).
Conclusion: To our knowledge, this is the first study demonstrating that carriage rate of MDRO in asylum seekers
remains high even after prolonged stay in the Netherlands. Longitudinal data on MDRO carriage after arrival in
countries with a low MDRO prevalence are needed to determine optimal screening strategies, infection control
measures and empirical antibiotic therapy.
Keywords: Multidrug resistant organisms, MRSA, Asylum seekers, Carriage rate
Background
During the last decade, millions of refugees have entered
European grounds as a result of warfare, violence, polit-
ical instability and poverty in several Asian, African and
Middle Eastern areas. Furthermore, ongoing civil wars in
Syria and Afghanistan have led to an unprecedented
influx of refuge seekers in Europe [1]. Several studies
have been conducted on carriage of multidrug-resistant
organisms (MDRO) in asylum seekers. A recently pub-
lished systematic review and meta-analysis on antimicro-
bial resistance amongst migrants in Europe, showed a
pooled prevalence of any detected antimicrobial resistance
(AMR) carriage or infection of 25.4% (95% CI 19.1–31.8).
The pooled prevalence of methicillin-resistant Staphylo-
coccus aureus (MRSA) was 7.8% (95% CI 4.8–10.7), and of
multidrug-resistant Gram negative bacteria (MDRGN)
27.2% (95% CI 17.6–36.8) [2].
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The high proportion of MDRO carriage among asylum
seekers may have implications for countries with low
MDRO prevalence like the Netherlands. Previously studied
MDRO carriage rate amongst asylum seekers in need of
medical care in the Netherlands was compared to the
MDRO rate in the Dutch hospitalized population. A preva-
lence of 21.4% compared to 5.1% for multi-drug resistant
Enterobacteriaceae (MDRE) and 9.7% versus 1.3% for
MRSA in the asylum seekers population and the Dutch
population was found, respectively. These findings support
a policy of MDRO screening amongst asylum seekers in
the Dutch setting [3].
The current Dutch protocol recommends screening of
all asylum seekers for MRSA and MDRGN carriage at
hospital admission or emergency care visit, regardless of
other risk factors [4, 5]. The protocol does not provide
information on the needs of screening in relation to the
time that elapsed since arrival into the country. Informa-
tion on duration of MDRO carriage is available for trav-
elers. In a Dutch study, 83.2% of travelers who tested
positive for MDRGN after visiting high prevalence coun-
tries, were spontaneously decolonized within 6 months
after returning to the Netherlands [6]. The same pattern
was observed in a German study in which 91.4% of
returning travelers who tested positive for ESBL, were
decolonized after 6 months [7]. Rational screening for
MDRO in asylum seekers in the Netherlands can be
improved based on information on the duration of
MDRO carriage in asylum seekers after arrival in the
Netherlands and can be more targeted based on risk
factors for MDRO carriage within the group of asy-
lum seekers.
In this retrospective study, we examine MDRO car-
riage among asylum seekers focusing on the time that
elapsed since arrival in the Netherlands.
Material and methods
Asylum seeker procedure in the Netherlands and the
Certe laboratory
Almost all asylum seekers arriving in the Netherlands
start their asylum procedure at the national reception
center for asylum seekers in the northeastern part of the
Netherlands. Asylum seekers who are in need of (direct)
medical care will report at the health care services in the
asylum seeker center. The general practitioner of the
health care services may refer the asylum seeker to a
hospital in the area. More information on the asylum
seeker procedure in the Netherlands can be found in a
previously published paper [3]. The Certe laboratory
performed all the routine microbiological diagnostics for
this northeastern part of the Netherlands, including
samples from eight hospitals, general practitioners, nurs-
ing homes and asylum seeker centers in the region.
Study design
Data was retrospectively collected from the Certe labora-
tory and the national health care system for asylum
seekers. Study material included screening samples for
MDRO carriage before admission (throat, rectum, and
nose) and clinical samples (e.g. blood, wounds, and uro-
genital) from asylum seekers. All of these samples were
obtained as part of the standard care. EUCAST guidelines
were used for susceptibility interpretation [8]. Patients
who tested negatively during their first visit at the hospital,
were retested on re-admission or when they visited the
emergency department. Results from these samples be-
tween January 1st 2014 and December 31st 2016, were
aggregated. We focused on MRSA, Vancomycin Resistant
Enterococci (VRE) and multidrug-resistant Enterobac-
teriaceae (MDRE). In MDRE three resistance patterns
were distinguished: Extended Spectrum Beta-Lactamase
(ESBL)-production, Fluoroquinolone plus Aminoglycoside
Resistant Enterobacteriaceae (QARE),
Carbapenemase-Producing Enterobacteriaceae (CPE) [3].
Selection of participants
All asylum seekers are registered on the asylum seeker
center’s address. The postal codes referring to these
addresses were used to identify patients as asylum seekers
for the study. Demographic data such as age, sex, and date
of sampling were collected from the laboratory system.
Country of origin and arrival date in the Netherlands was
documented using the health care system for asylum
seekers. In case the arrival date was missing, the date of
first visit to a general practitioner was used.
Bacterial detection and analysis
MRSA
Screening samples were incubated on blood agar (Media-
products BV) for growth control, a selective Chrom ID
MRSA (bioMérieux) and a Mueller Hinton broth with NaCl
2.5% (Mediaproducts BV). The selective broth was also
subcultured on selective Chrom ID MRSA (bioMérieux)
after one-night incubation. Growth of S. aureus was con-
firmed by Staphaurex Plus (Oxoid) and coagulase-test [3].
MDRE
The selective agar plates used for MDRE detection were
McConkey with ciprofloxacin 0,5mg/l and gentamicin 2
mg/l (Mediaproducts BV), a ChromID ESBL and a Chro-
mID Carbapenemase agar (both bioMérieux). Presence of
ESBL was confirmed with cefotaxime-clavulanate, ceftazi-
dime- clavulanate and cefepime-clavulanate Etest strips
(bioMérieux). Possible CPE was confirmed by CIM
test and PCR and typed by the national reference net-
work for CPE at the RIVM (National Institute for
Public Health) [3].
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VRE
For selective culture of Vancomycin Resistant Entero-
coccus faecalis or Enterococcus faecium (VRE,) rectal
swabs were incubated for 2 nights at 35 °C in Brain Heart
Infusion broth with 2% NaCl and 16mg/l gentamicin plus
16mg/l vancomycin. Subcultures were made on chromID
VRE agar plate (bioMérieux). VRE confirmation was done
by VanA/ VanB PCR using GeneXpert (Cepheid).
Statistical analysis
Data was analyzed with SPSS Version 23.0. Descriptive
statistics were used for the general characteristics and
the duration of MDRO carriage. Data is presented as
median with 25–75% inter quartile range (IQR) as
appropriate. To study the carriage rate of MRSA and
MDRE over time, all dates of first samples taken were
compared to the arrival date in the Netherlands. Car-
riage duration through time was analyzed by four-weeks
periods. Due to small population size the last period was
defined as week 53 and after and is represented as one
group. For determining MDRO carriage over time, we
excluded all clinical samples, considering no antibiotic
usage data were available.
Results
General characteristics
From January 2014 through December 2016, 2091 asy-
lum seekers were tested for MDROs as part of their
standard care. Screening and clinical samples were
obtained based on the cause of visit/admission to the
hospital and the anticipated causative agents leading to
different number of asylum seekers tested for MRSA
and MDRE. General characteristics of both study groups
can be found in Table 1.
In total, 1954 asylum seekers were tested for MRSA,
of which 185 (9.3%) were positive. Nine hundred seventy
two asylum seekers were all tested negative for VRE.
Furthermore, 1789 asylum seekers were tested for
MDRE of which 331 (18.5%) tested positive. Specifics re-
garding screening to clinical samples ratio can be found
in Table 1. MRSA and MDRE were relatively more
frequently detected in asylum seekers originating from
Iraq (19.1 and 43.2%, respectively) and Syria (15.8 and
39.9%, respectively). An overview of the country of ori-
gin of the study group and the number of people tested
positive for MDRO within the total group, originating
from the same country can be found in Fig. 1.
Resistance patterns in MDRE
E. coli was the most frequently detected MDRE species
(n = 301). The most frequent resistance pattern detected
was ESBL-production followed by a combination of
ESBL-production and Fluoroquinolone/Aminoglycoside
resistance. Of note, one of the strains co-exhibited all
three patterns of resistance. The carrier of this specific
strain originated from Syria. Detailed numbers of species
with specific resistance patterns can be found in Table 2.
MDRO carriage
MDRO carriage in the first culture
Figures 2 and 3 show the carriage rate of MRSA and
MDRE in asylum seekers in their first obtained sample
in percentages over time. For MRSA, the median time
after arrival in the last group (over 53 weeks) was 1022
days (IQR 494–1892) and for MDRE was 1063 days
(IQR 510–1950).
MDRO carriage during follow-up
MRSA Of the 1954 asylum seekers tested for MRSA,
follow-up screening samples were performed in 442 of
them after a median of 60 days (IQR 27–109) after the
first sample was obtained. Forty seven asylum seekers
that tested positive for MRSA, were followed up with
Table 1 General characteristics of the study population
Number of asylum seekers (n = 2091)
Sex (female (%)) 1270 (60.7)
Age in years median (IQRb) 26 (20–34)
Number of days in the Netherlands until first sample (IQR) 67 (4–235)
Number of asylum seekers Number of MDRO positive asylum seekers (%)
Total number of asylum seekers tested for MRSA analysis 1954 185 (9.5)
Screening analysis 1777 159 (8.9)
Clinical analysis 177 26 (14.7)
Total number of asylum seekers tested for MDRE analysis 1789 331 (18.5)a
Screening analysis 1555 298 (19.2)
Clinical analysis 234 48 (20.5)
a 15 positive asylum seekers had both for screening and clinical samples
b IQR Interquartile range
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Fig. 1 a Number of asylum seekers that tested positive for MRSA compared to the number of asylum seekers that tested negative for MRSA
within country of origin. b Number of asylum seekers that tested positive for MDRE compared to the number of asylum seekers that tested
negative for MDRE within country of origin
Table 2 Number of isolates belonging to different microbial species and the respective resistance patterns they exhibited
Microbial species ESBLa QAREb ESBL + QARE CPEc + ESBL CPE + ESBL + QARE
Escherichia coli n = 301 240 12 48 1 0
Klebsiella pneumonia n = 26 19 0 7 0 0
Klebsiella oxytoca 0 0 1 0 1
Proteus mirabilis 5 2 0 0 0
Morganella morganii 0 0 2 0 0
Enterobacter cloacae 3 0 1 0 0
Citrobacter freundii 1 0 0 0 0
Total number of strains (n = 343d) 268 14 59 1 1
a ESBL Extended Spectrum Beta-Lactamase
b QARE Fluoroquinolone plus aminoglycoside resistant Enterobacteriaceae
c CPE Carbapenemase-Producing Enterobacteriaceae
d Total number of isolates (n = 343) is higher than the number of positive sample because same samples were positive for more than one MDRE
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screening samples. Twenty five of the asylum seekers
who tested positive for MRSA in the first obtained sam-
ple, tested positive in their follow-up samples which
were obtained after a median of 80 days (IQR 20.5–101).
Six of the asylum seekers who tested positive for
MRSA in the first obtained sample, tested negative in
the subsequent samples which were obtained after a
median of 48.5 days (IQR 43.75–147). It is unknown if
these patients received eradication or treatment before
retesting.
There were 16 asylum seekers who initially tested
negative for MRSA but tested positive for MRSA in re-
peated screening sample obtained after a median 63 days
(IQR 8.5–109).
MDRE Of the 1789 asylum seekers tested for MDRE, fol-
low up screening samples were performed in 365 of them
after a median of 57 days (IQR 27–104) after the first
sample was obtained. Seventy-one of the asylum
seekers who tested positive for MDRE, were followed
up with screening samples. Thirty-eight of the asylum
seekers who tested positive for MDRE in the first
obtained sample, tested positive in their follow-up
samples which were obtained after a median of 60.5
(IQR 16.8–99.8).
Twenty nine of the asylum seekers who tested positive
for MDRE in the first obtained sample, tested negative
in the subsequent samples which were taken after a me-
dian of 87 days (IQR 39–179). It is unknown if these
patients received treatment before the retesting. There
were four asylum seekers who initially tested negative
for MDRE but tested positive for MDRE in repeated
screening samples taken after a median of 28.5 days
(IQR 5–163.8).
Fig. 2 Percentage of MRSA in first obtained sample in relation to time (weeks) after arrival in the Netherlands. Repeated samples are excluded
Fig. 3 Percentage of MDRE in first obtained sample in relation to time (weeks) after arrival in the Netherlands. Repeated samples are excluded
Ravensbergen et al. Antimicrobial Resistance and Infection Control             (2019) 8:6 Page 5 of 7
Discussion
In this study, a large number of both screening and clin-
ical samples were collected from 2091 asylum seekers.
The most frequently isolated resistant microbes were
MRSA and ESBL-producing E. coli. The percentage of
MRSA and MDRE in asylum seekers who tested positive
for MRSA and/or MDRE changed over time. However,
no clear pattern of decline or increase was observed.
Several studies have described MDRO carriage or out-
breaks amongst Syrian refugees. In a Swiss study, 261
refugees were screened for MRSA of which 41 (15.7%)
tested positive. Furthermore 240 refugees were screened
for ESBL-producing Gram negatives of which 57 (23.7%)
tested positive [9]. In addition, studies in Germany have
shown MDRO prevalence in asylum seekers ranging
between 24.7% and 60.8%. The main resistant strains iso-
lated were MRSA, and ESBL-producing Enterobacteria-
ceae [10, 11]. The wide range of carriage observed among
these studies reflects the differences among the study
population such as age, country of origin, included sam-
ples, e.g. screening and/or clinical, risk factors like previ-
ous hospitalization and differences in sampling strategies
and laboratory methods. Our findings align with high
MDRO range amongst this vulnerable population.
Studies have shown that the duration of MDRO
colonization in humans vary across strains – e.g. the me-
dian clearance for MRSA varied between 5.9 and 9
months [12, 13]. Regarding ESBL-producing Enterobac-
teriaceae, a median clearance of 6.6 months was ob-
served [14]. In an Australian study, 26 out of 48 (54%)
international travelers cleared all resistant E. coli within
2 months after their return, while 18% remained colo-
nized 6 months post-travel [15]. Furthermore, a study
from the Netherlands, a country of low prevalence for
MDROs, investigated MDRO carriage rate and its dur-
ation over time in travelers returning from high preva-
lence countries. One hundred thirteen people who were
negative for MDRGN before travelling tested positive
after returning to the Netherlands. 83.2% of them were
spontaneously decolonized within 6months after return-
ing to the Netherlands [6].
We therefore expected the MDRO prevalence amongst
our population group to decline over time, especially
when taking under consideration the low prevalence of
MDRO in the Netherlands. However, a significant per-
centage of our population group tested positive in their
first sample taken even after more than 1 year after ar-
rival in the Netherlands.
Multiple possible explanations for the prolonged dur-
ation of carriage of MDROs in this population can be
considered. Firstly, a large number of the study group
spent most of the study period living together in one of
the asylum seeker centers in the northern part of the
Netherlands. MDRO carriers could serve as a natural
reservoir, forming a cluster of such strains and close
contact within the facility could lead to transmission
[16]. Secondly, the possibility of MDRO strains being
part of the normal flora should be considered. In such
cases, the resistant strains colonize the gut microbiome
indefinitely and detecting them depends on the screen-
ing methods and their microbial load at the time of
screening.
Due to the retrospective aspect of this study we did not
have access to important information like traveling and
antibiotic consumption history. However, our study popu-
lation exhibited wide ranges regarding age, country of ori-
gin, and included both hospitalized and non-hospitalized
asylum seekers. No systematic screening upon arrival in
the Netherlands, and follow up screening was performed
in asylum seekers. Only in asylum seekers in need of med-
ical care multiple times or admitted to the wards, follow
up screening was performed.
Antibiotic consumption in general is low in the
Netherlands. The antibiotic consumption data by the
study population is unknown to us, but a small percent-
age of the asylum seekers population face health issues
such as infections and might have been treated with
antibiotics. This could have contributed to emergence of
resistant strains and/or prolonged duration of carriage
due to antibiotic pressure.
In order to confirm or reject our hypothesis regard-
ing prolonged duration of carriage, the next rational
step would be to perform a prospective, longitudinal
study of a cohort. However, it is unsure whether it
could be perceived as ethical to approach asylum
seekers for participation in a prospective trial upon
arrival considering their dependent position. More-
over, molecular analysis of the strains and thorough
examination of their phylogenetic relatedness could
reveal important information on transmission and
cluster formation.
Conclusion
In conclusion, our findings verify the high MDRO preva-
lence among the asylum seeker population. To our
knowledge, this is the first study demonstrating that car-
riage rate of MDRO remained high even after long term
stay in the Netherlands. This finding has consequences
for the optimal screening strategy, infection control
measures and empirical antibiotic therapy. A prospect-
ive, longitudinal study of a cohort should be performed
to confirm our findings. The dependent position of asy-
lum seekers should however be carefully considered in
the study design. Moreover, molecular analysis of the
strains and thorough examination of their phylogenetic
relatedness could reveal important information on trans-
mission and cluster formation.
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